BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30529211)

  • 1. Promising neuroprotective effects of β-caryophyllene against LPS-induced oligodendrocyte toxicity: A mechanistic study.
    Askari VR; Shafiee-Nick R
    Biochem Pharmacol; 2019 Jan; 159():154-171. PubMed ID: 30529211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effects of β-caryophyllene on LPS-induced primary microglia M
    Askari VR; Shafiee-Nick R
    Life Sci; 2019 Feb; 219():40-73. PubMed ID: 30620895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway.
    Bento AF; Marcon R; Dutra RC; Claudino RF; Cola M; Leite DF; Calixto JB
    Am J Pathol; 2011 Mar; 178(3):1153-66. PubMed ID: 21356367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
    Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
    Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: The role of CB2 and PPAR-γ receptors.
    Youssef DA; El-Fayoumi HM; Mahmoud MF
    Biomed Pharmacother; 2019 Feb; 110():145-154. PubMed ID: 30469079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Imipramine, a sphingomyelinase inhibitor, and β-caryophyllene improve their therapeutic effects on experimental autoimmune encephalomyelitis (EAE).
    Askari VR; Baradaran Rahimi V; Tabatabaee SA; Shafiee-Nick R
    Int Immunopharmacol; 2019 Dec; 77():105923. PubMed ID: 31711937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Caryophyllene Mitigates Collagen Antibody Induced Arthritis (CAIA) in Mice Through a Cross-Talk between CB2 and PPAR-γ Receptors.
    Irrera N; D'Ascola A; Pallio G; Bitto A; Mazzon E; Mannino F; Squadrito V; Arcoraci V; Minutoli L; Campo GM; Avenoso A; Bongiorno EB; Vaccaro M; Squadrito F; Altavilla D
    Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31370242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-Caryophyllene, a Plant-Derived CB2 Receptor Agonist, Protects SH-SY5Y Cells from Cadmium-Induced Toxicity.
    Mannino F; Pallio G; Imbesi C; Scarfone A; Puzzolo D; Micali A; Freni J; Squadrito F; Bitto A; Minutoli L; Irrera N
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioprotective Effect of Resveratrol: an Emerging Therapeutic Role for Oligodendroglial Cells.
    Rosa PM; Martins LAM; Souza DO; Quincozes-Santos A
    Mol Neurobiol; 2018 Apr; 55(4):2967-2978. PubMed ID: 28456938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Caryophyllene protects the C6 glioma cells against glutamate-induced excitotoxicity through the Nrf2 pathway.
    Assis LC; Straliotto MR; Engel D; Hort MA; Dutra RC; de Bem AF
    Neuroscience; 2014 Oct; 279():220-31. PubMed ID: 25194788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-caryophyllene protects against diet-induced dyslipidemia and vascular inflammation in rats: Involvement of CB2 and PPAR-γ receptors.
    Youssef DA; El-Fayoumi HM; Mahmoud MF
    Chem Biol Interact; 2019 Jan; 297():16-24. PubMed ID: 30343038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
    Ribeiro R; Yu F; Wen J; Vana A; Zhang Y
    Neuroscience; 2013 Dec; 254():427-42. PubMed ID: 24036373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4-induced peroxisome proliferator-activated receptor gamma activation inhibits NF-kappaB trans activation in central nervous system (CNS) glial cells and protects oligodendrocyte progenitors under neuroinflammatory disease conditions: implication for CNS-demyelinating diseases.
    Paintlia AS; Paintlia MK; Singh I; Singh AK
    J Immunol; 2006 Apr; 176(7):4385-98. PubMed ID: 16547277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice.
    Segat GC; Manjavachi MN; Matias DO; Passos GF; Freitas CS; Costa R; Calixto JB
    Neuropharmacology; 2017 Oct; 125():207-219. PubMed ID: 28729222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise.
    Sharma C; Al Kaabi JM; Nurulain SM; Goyal SN; Kamal MA; Ojha S
    Curr Pharm Des; 2016; 22(21):3237-64. PubMed ID: 26965491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanistic review on immunomodulatory effects of selective type two cannabinoid receptor β-caryophyllene.
    Baradaran Rahimi V; Askari VR
    Biofactors; 2022 Jul; 48(4):857-882. PubMed ID: 35648433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental Cannabinoid 2 Receptor Activation by Phyto-Derived and Synthetic Cannabinoid Ligands in LPS-Induced Interstitial Cystitis in Mice.
    Berger G; Arora N; Burkovskiy I; Xia Y; Chinnadurai A; Westhofen R; Hagn G; Cox A; Kelly M; Zhou J; Lehmann C
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31766439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Caryophyllene (BCP) ameliorates MPP+ induced cytotoxicity.
    Wang G; Ma W; Du J
    Biomed Pharmacother; 2018 Jul; 103():1086-1091. PubMed ID: 29710667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis.
    Alberti TB; Barbosa WL; Vieira JL; Raposo NR; Dutra RC
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarial Drug Artemether Inhibits Neuroinflammation in BV2 Microglia Through Nrf2-Dependent Mechanisms.
    Okorji UP; Velagapudi R; El-Bakoush A; Fiebich BL; Olajide OA
    Mol Neurobiol; 2016 Nov; 53(9):6426-6443. PubMed ID: 26607631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.